Net profit of Jagsonpal Pharmaceuticals rose 85.35% to Rs 6.58 crore in the quarter ended March 2025 as against Rs 3.55 crore during the previous quarter ended March 2024. Sales rose 34.65% to Rs 58.56 crore in the quarter ended March 2025 as against Rs 43.49 crore during the previous quarter ended March 2024.
For the full year,net profit rose 146.48% to Rs 55.36 crore in the year ended March 2025 as against Rs 22.46 crore during the previous year ended March 2024. Sales rose 28.76% to Rs 268.72 crore in the year ended March 2025 as against Rs 208.70 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 58.56 | 43.49 | 35 | 268.72 | 208.70 | 29 |
| OPM % | 14.89 | 6.12 | - | 19.00 | 11.05 | - |
| PBDT | 11.23 | 4.93 | 128 | 58.30 | 31.53 | 85 |
| PBT | 8.92 | 4.53 | 97 | 50.17 | 29.87 | 68 |
| NP | 6.58 | 3.55 | 85 | 55.36 | 22.46 | 146 |